BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17347804)

  • 1. Reporting of adverse drug reactions may be influenced by feedback to the reporting doctor.
    Wallerstedt SM; Brunlöf G; Johansson ML; Tukukino C; Ny L
    Eur J Clin Pharmacol; 2007 May; 63(5):505-8. PubMed ID: 17347804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A small economic inducement to stimulate increased reporting of adverse drug reactions--a way of dealing with an old problem?
    Bäckström M; Mjörndal T
    Eur J Clin Pharmacol; 2006 May; 62(5):381-5. PubMed ID: 16572320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse drug reaction reporting by nurses in Sweden.
    Bäckström M; Ekman E; Mjörndal T
    Eur J Clin Pharmacol; 2007 Jun; 63(6):613-8. PubMed ID: 17404719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse drug reaction reporting by general medical practitioners and retail pharmacists in Harare--a pilot study.
    Ball D; Tisócki T
    Cent Afr J Med; 1998 Aug; 44(8):190-5. PubMed ID: 10101417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous reporting of adverse drug reactions by nurses.
    Bäckström M; Mjörndal T; Dahlqvist R
    Pharmacoepidemiol Drug Saf; 2002 Dec; 11(8):647-50. PubMed ID: 12512239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom.
    Belton KJ; Lewis SC; Payne S; Rawlins MD; Wood SM
    Br J Clin Pharmacol; 1995 Mar; 39(3):223-6. PubMed ID: 7619660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of a changed legislation on reporting of adverse drug reactions in Sweden, with focus on nurses' reporting.
    Karlsson SA; Jacobsson I; Boman MD; Hakkarainen KM; Lövborg H; Hägg S; Jönsson AK
    Eur J Clin Pharmacol; 2015 May; 71(5):631-6. PubMed ID: 25845655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Founding an adverse drug reaction (ADR) network: a method for improving doctors spontaneous ADR reporting in a general hospital.
    Goldstein LH; Berlin M; Saliba W; Elias M; Berkovitch M
    J Clin Pharmacol; 2013 Nov; 53(11):1220-5. PubMed ID: 23852627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expectations of general practitioners and specialist doctors regarding the feedback received after reporting an adverse drug reaction.
    Cornelissen L; van Puijenbroek E; van Grootheest K
    Pharmacoepidemiol Drug Saf; 2008 Jan; 17(1):76-81. PubMed ID: 17987591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital.
    Vallano A; Cereza G; Pedròs C; Agustí A; Danés I; Aguilera C; Arnau JM
    Br J Clin Pharmacol; 2005 Dec; 60(6):653-8. PubMed ID: 16305591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal.
    Marques J; Ribeiro-Vaz I; Pereira AC; Polónia J
    Int J Pharm Pract; 2014 Aug; 22(4):275-82. PubMed ID: 24188533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physicians' attitudes and adverse drug reaction reporting : a case-control study in Portugal.
    Herdeiro MT; Figueiras A; Polónia J; Gestal-Otero JJ
    Drug Saf; 2005; 28(9):825-33. PubMed ID: 16119975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse drug reactions reporting by physicians in Ibadan, Nigeria.
    Okezie EO; Olufunmilayo F
    Pharmacoepidemiol Drug Saf; 2008 May; 17(5):517-22. PubMed ID: 18404621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of information letters on the reporting rate of adverse drug reactions and the quality of the reports: a randomized controlled study.
    Johansson ML; Hägg S; Wallerstedt SM
    BMC Clin Pharmacol; 2011 Sep; 11():14. PubMed ID: 21899766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attitudes to adverse drug reaction reporting in the Northern Region.
    Bateman DN; Sanders GL; Rawlins MD
    Br J Clin Pharmacol; 1992 Nov; 34(5):421-6. PubMed ID: 1467137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring drug safety in Astrakhan, Russia.
    Kirilochev OO; Dorfman IP; Umerova AR
    Int J Risk Saf Med; 2015; 27 Suppl 1():S33-4. PubMed ID: 26639700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attitudes to adverse drug reactions and their reporting among medical practitioners.
    Robins AH; Weir M; Biersteker EM
    S Afr Med J; 1987 Jul; 72(2):131-4. PubMed ID: 3616786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attitudes among hospital physicians to the reporting of adverse drug reactions in Sweden.
    Ekman E; Bäckström M
    Eur J Clin Pharmacol; 2009 Jan; 65(1):43-6. PubMed ID: 18825377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attitudes to adverse drug reaction reporting by medical practitioners in a Northern Italian district.
    Cosentino M; Leoni O; Banfi F; Lecchini S; Frigo G
    Pharmacol Res; 1997 Feb; 35(2):85-8. PubMed ID: 9175573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Underreporting of adverse drug reactions: attitudes of Irish doctors.
    Williams D; Feely J
    Ir J Med Sci; 1999; 168(4):257-61. PubMed ID: 10624366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.